Strategies for Supporting Early Diagnosis and Implementation of Amyloid-Targeting Therapies in Alzheimer Disease : Episode 13
Opinion
Video
Criteria for Discontinuing Treatment With an Amyloid-Targeting Therapy
Panelists discuss how treatment continuation decisions for amyloid-targeting therapies involve comprehensive assessment of multiple factors including cognitive and functional changes measured through standardized tools, occurrence and severity of adverse events, treatment adherence capabilities, impact on patient/caregiver quality of life, disease progression rate, emerging safety signals, and ongoing dialogue about evolving treatment goals and expectations.
Video content above is prompted by the following:
- How do you decide whether to continue or discontinue treatment with an amyloid-targeting therapy?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Videos
Related Content
